Disclaimer: This is an early beta prototype. If you find any error, with data or functionality, please let us know via this page.

Conditions

Interventions

Lay summary

The primary objective of this study is to evaluate the pharmacokinetics and pharmacodynamics of reslizumab in pediatric patients with asthma 6 to less than 12 years of age following administration of a single subcutaneous (sc) dose.

Documents

 

Publications

We have no "publications" for this trial. Help us by contributing data.

Registries